Panda Surgical
Panda Surgical Limited, a University College London spinout based in London, UK, is developing the first-ever handheld robotic platform for minimally invasive neurosurgery. Their technology integrates advanced handheld robotics with AI-powered software to enhance neurosurgeons' dexterity and decision-making in confined surgical spaces, enabling safer, more effective, and widely accessible complex neurosurgical procedures. The platform features exchangeable wristed surgical tools and aims to expand access to minimally invasive brain and spine surgeries by overcoming current limitations of dexterity and control. Panda Surgical has completed the world's first live-animal study demonstrating the system's precision and safety, and secured over £1 million in funding from the NIHR i4i Product Development Award to advance development and conduct the first human clinical trial. The company is led by experts in surgical robotics, AI, and neurosurgery, positioning it strongly in the surgical robotics market with a focus on regulatory approval and commercialization in the US and Europe.
Panda Surgical
Panda Surgical Limited, a University College London spinout based in London, UK, is developing the first-ever handheld robotic platform for minimally invasive neurosurgery. Their technology integrates advanced handheld robotics with AI-powered software to enhance neurosurgeons' dexterity and decision-making in confined surgical spaces, enabling safer, more effective, and widely accessible complex neurosurgical procedures. The platform features exchangeable wristed surgical tools and aims to expand access to minimally invasive brain and spine surgeries by overcoming current limitations of dexterity and control. Panda Surgical has completed the world's first live-animal study demonstrating the system's precision and safety, and secured over £1 million in funding from the NIHR i4i Product Development Award to advance development and conduct the first human clinical trial. The company is led by experts in surgical robotics, AI, and neurosurgery, positioning it strongly in the surgical robotics market with a focus on regulatory approval and commercialization in the US and Europe.